Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.120
-0.010 (-0.88%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Biofrontera Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$2.75
Upside
+145.54%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy Maintains $7 → $2.75 | Strong Buy | Maintains | $7 → $2.75 | +145.54% | May 19, 2025 |
| Benchmark | Benchmark | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +525.00% | Nov 15, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +525.00% | Aug 16, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +1,507.14% | Aug 31, 2023 |
| Benchmark | Benchmark | Strong Buy Maintains $140 → $18 | Strong Buy | Maintains | $140 → $18 | +1,507.14% | Jul 5, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +12,400.00% | May 15, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +12,400.00% | Mar 9, 2023 |
| Benchmark | Benchmark | Strong Buy Reiterates $220 → $140 | Strong Buy | Reiterates | $220 → $140 | +12,400.00% | Jan 31, 2023 |
| Benchmark | Benchmark | Strong Buy Initiates $220 | Strong Buy | Initiates | $220 | +19,542.86% | Dec 15, 2021 |
| Roth Capital | Roth Capital | Strong Buy Initiates $400 | Strong Buy | Initiates | $400 | +35,614.29% | Nov 24, 2021 |